#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Retinal dystrophy Synovial sarcoma metastatic Vaginal cancer Scedosporium infection Ocular myasthenia Corneal neovascularisation Depression Craniocerebral injury Pouchitis Non-Hodgkin's lymphoma unspecified histology aggressive recurrent Dementia Alzheimer's type Tuberous sclerosis complex High-grade B-cell lymphoma Huntington's disease Ventricular fibrillation More trials…

    Learn about Rare Diseases

    Breast angiosarcoma metastatic – Life with Disease Leiomyosarcoma recurrent – Basic Information Antisynthetase syndrome Ewing’s sarcoma – Treatment Synovial sarcoma – Basic Information Prader-Willi syndrome – Trials in Disease Haemophilia B with anti factor IX – Life with Disease Shprintzen-Goldberg syndrome – Basic Information Glomerulonephritis membranous Prolymphocytic leukaemia – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Levothyroxine Sodium Diroximel Fumarate Atazanavir Cyclophosphamide Nms-03305293 Ly3454738 Clopidogrel Hydrogen Sulfate GSKVX000000040033 AZD4360 Pivekimab Sunirine 18F-Psma-1007 Ergocalciferol Bp Glucose, Anhydrous Cholic Acid Brigatinib Ranibizumab Samuraciclib Io103 Acetate Df1001 Gen1047 More therapies…

    Learn about Your Condition

    Suicidal ideation Immune system disorder Hip arthroplasty Anal cancer stage II Iron deficiency anaemia Thermal burn Breast cancer recurrent Pre-eclampsia Left ventricular dysfunction Stress cardiomyopathy Richter's syndrome Dizziness Short-bowel syndrome Chronic hepatitis B Palpitations More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Nervous System Diseases

  • Study on the Safety and Effectiveness of Alprazolam for Treating Long Seizures in Patients Aged 12 and Older

    Recruiting

    3 1
    Investigated Drugs:
    • Alprazolam
    Bulgaria Czechia France Germany Hungary Italy +2

  • Study on A49, A52, and Litenimod Sodium for Patients with Glioblastoma

    Recruiting

    2 1 1
    Investigated Diseases:
    • Glioblastoma
    Investigated Drugs:
    • A49
    • A52
    • Litenimod Sodium
    France

  • Study on Monitoring Ocrelizumab Levels for Personalized Treatment in Patients with Relapsing-Remitting and Primary Progressive Multiple Sclerosis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Multiple sclerosis
    Investigated Drugs:
    • Ocrelizumab
    Czechia

  • Study Comparing the Effects of Ozanimod and Fingolimod in Children and Adolescents with Relapsing Remitting Multiple Sclerosis

    Recruiting

    3 1 1
    Investigated Drugs:
    • Ozanimod Hydrochloride
    • Fingolimod
    Italy Poland Portugal Romania Spain

  • Study on the Effects of Sodium Lactate and Electrolyte Solution in Comatose Patients After Cardiac Arrest

    Recruiting

    2 1 1
    Investigated Diseases:
    • Brain injury
    • Cardiac arrest
    • Post cardiac arrest syndrome
    Investigated Drugs:
    • Magnesium Chloride Hexahydrate
    • Sodium Acetate Trihydrate
    • Sodium Gluconate
    Belgium

  • Study on Esketamine Hydrochloride and Sodium Chloride for Patients with Severe Acute Brain Injury

    Recruiting

    3 1 1
    Investigated Drugs:
    • Esketamine Hydrochloride
    • Sodium Chloride
    Denmark
Previous Page
1 … 31 32 33 34 35 … 141
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!